179 related articles for article (PubMed ID: 37494666)
1. A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.
Sassi G; Licata G; Ventriglia G; Wouters A; Lemaitre P; Seurinck R; Mori A; Grieco GE; Bissenova S; Ellis D; Caluwaerts S; Rottiers P; Vandamme N; Mathieu C; Dotta F; Gysemans C; Sebastiani G
Diabetes; 2023 Oct; 72(10):1470-1482. PubMed ID: 37494666
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Delivery of Proinsulin and IL-10 via
Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
Front Immunol; 2020; 11():1103. PubMed ID: 32582188
[TBL] [Abstract][Full Text] [Related]
3. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice.
Takiishi T; Korf H; Van Belle TL; Robert S; Grieco FA; Caluwaerts S; Galleri L; Spagnuolo I; Steidler L; Van Huynegem K; Demetter P; Wasserfall C; Atkinson MA; Dotta F; Rottiers P; Gysemans C; Mathieu C
J Clin Invest; 2012 May; 122(5):1717-25. PubMed ID: 22484814
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells.
Takiishi T; Cook DP; Korf H; Sebastiani G; Mancarella F; Cunha JP; Wasserfall C; Casares N; Lasarte JJ; Steidler L; Rottiers P; Dotta F; Gysemans C; Mathieu C
Diabetes; 2017 Feb; 66(2):448-459. PubMed ID: 28108611
[TBL] [Abstract][Full Text] [Related]
5. miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes.
Ventriglia G; Mancarella F; Sebastiani G; Cook DP; Mallone R; Mathieu C; Gysemans C; Dotta F
Diabetologia; 2020 Jan; 63(1):124-136. PubMed ID: 31659408
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.
Lang J; Wang X; Liu K; He D; Niu P; Cao R; Jin L; Wu J
Appl Microbiol Biotechnol; 2017 Oct; 101(20):7653-7662. PubMed ID: 28889199
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
[TBL] [Abstract][Full Text] [Related]
8. Plasma miR-193b-3p Is Elevated in Type 2 Diabetes and Could Impair Glucose Metabolism.
Hu H; Zhao M; Li Z; Nie H; He J; Chen Z; Yuan J; Guo H; Zhang X; Yang H; Wu T; He M
Front Endocrinol (Lausanne); 2022; 13():814347. PubMed ID: 35712251
[TBL] [Abstract][Full Text] [Related]
9. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
[TBL] [Abstract][Full Text] [Related]
12. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
[TBL] [Abstract][Full Text] [Related]
13. Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Lactococcus lactis.
Robert S; Van Huynegem K; Gysemans C; Mathieu C; Rottiers P; Steidler L
Benef Microbes; 2015; 6(4):591-601. PubMed ID: 25576592
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.
Ma Y; Liu J; Hou J; Dong Y; Lu Y; Jin L; Cao R; Li T; Wu J
PLoS One; 2014; 9(8):e105701. PubMed ID: 25157497
[TBL] [Abstract][Full Text] [Related]
15. Two Novel MicroRNA Biomarkers Related to β-Cell Damage and Their Potential Values for Early Diagnosis of Type 1 Diabetes.
Liu L; Yan J; Xu H; Zhu Y; Liang H; Pan W; Yao B; Han X; Ye J; Weng J
J Clin Endocrinol Metab; 2018 Apr; 103(4):1320-1329. PubMed ID: 29370422
[TBL] [Abstract][Full Text] [Related]
16. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
Niwa Y; Yamada S; Sonohara F; Kurimoto K; Hayashi M; Tashiro M; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
J Transl Med; 2019 Jan; 17(1):1. PubMed ID: 30602370
[TBL] [Abstract][Full Text] [Related]
17. Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes.
Lakhter AJ; Pratt RE; Moore RE; Doucette KK; Maier BF; DiMeglio LA; Sims EK
Diabetologia; 2018 May; 61(5):1124-1134. PubMed ID: 29445851
[TBL] [Abstract][Full Text] [Related]
18. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
20. Profiling the circulating miRNAs in mice exposed to gram-positive and gram-negative bacteria by Illumina small RNA deep sequencing.
Rau CS; Wu SC; Yang JC; Lu TH; Wu YC; Chen YC; Tzeng SL; Wu CJ; Hsieh CH
J Biomed Sci; 2015 Jan; 22(1):1. PubMed ID: 25563241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
